Citadel Advisors’s BioLineRX BLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$68.3K Buy
+14,954
New +$68.3K ﹤0.01% 5390
2025
Q1
Sell
-383
Closed -$3.25K 5988
2024
Q4
$3.25K Buy
+383
New +$3.25K ﹤0.01% 5777
2024
Q3
Hold
0
5840
2024
Q2
Hold
0
5946
2024
Q1
Sell
-605
Closed -$38K 6134
2023
Q4
$38K Sell
605
-869
-59% -$54.6K ﹤0.01% 5215
2023
Q3
$107K Sell
1,474
-3,845
-72% -$280K ﹤0.01% 4816
2023
Q2
$339K Buy
+5,319
New +$339K ﹤0.01% 3997
2022
Q3
Sell
-569
Closed -$29K 5905
2022
Q2
$29K Buy
+569
New +$29K ﹤0.01% 5637
2022
Q1
Hold
0
6363
2021
Q4
Sell
-4,129
Closed -$451K 6476
2021
Q3
$451K Buy
4,129
+3,002
+266% +$328K ﹤0.01% 4635
2021
Q2
$127K Buy
+1,127
New +$127K ﹤0.01% 5848
2021
Q1
Sell
-1,233
Closed -$124K 6265
2020
Q4
$124K Buy
+1,233
New +$124K ﹤0.01% 4632
2019
Q2
Sell
-56
Closed -$14K 4644
2019
Q1
$14K Sell
56
-41
-42% -$10.3K ﹤0.01% 4437
2018
Q4
$26K Buy
+97
New +$26K ﹤0.01% 4203
2018
Q2
Sell
-22
Closed -$11K 4178
2018
Q1
$11K Sell
22
-14
-39% -$7K ﹤0.01% 3910
2017
Q4
$24K Buy
36
+17
+89% +$11.3K ﹤0.01% 3746
2017
Q3
$13K Buy
+19
New +$13K ﹤0.01% 3576
2017
Q2
Sell
-177
Closed -$102K 3653
2017
Q1
$102K Buy
177
+144
+436% +$83K ﹤0.01% 3324
2016
Q4
$18K Buy
33
+6
+22% +$3.27K ﹤0.01% 3466
2016
Q3
$19K Buy
+27
New +$19K ﹤0.01% 3439
2014
Q2
Sell
-54
Closed -$72K 3460
2014
Q1
$72K Buy
+54
New +$72K ﹤0.01% 3160